Clinical Trial Update: Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data

View source ↗

Summary

This study analyzes characteristics of patients with type 2 diabetes mellitus who were treated with dapagliflozin versus sitagliptin, using commercial claims an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)
• Januvia (sitagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus Type 2 | Status: COMPLETED